Leveraging Immunologic Pathways in the Management of Patients With Psoriatic Arthritis or Axial Spondylarthritis: Clinical Pearls for the Advanced Practice Provider
Pre-test

Questions marked with a * are required
100%
Contact Information
Which of the following is the most reliable indicator for identifying active disease in patients with psoriatic arthritis (PsA)? 
A 35-year-old man with psoriatic arthritis (PsA) has failed treatment with methotrexate and shows inadequate response to a TNF inhibitor. According to the latest treatment guidelines, which of the following would be the most appropriate next step in his treatment? 
How often should you reassess disease activity and consider treatment adjustment when using a treat-to-target approach for axial spondyloarthritis (axSpA)?
Sarah, a 28-year-old woman, presents with a 3-year history of low back pain, morning stiffness lasting 1 hour, and occasional heel pain. She was recently diagnosed with axial spondyloarthritis. Initial treatment with NSAIDs provided minimal relief. Her BASDAI score is 5.2 and MRI shows active inflammation in the sacroiliac joints. Her CRP is mildly elevated at 15 mg/L. Which of the following is the most appropriate next step in Sarah's management?
Powered by QuestionPro